Document is current
Any future updates will be listed below
-
Authors
Ahadi, Sara https://orcid.org/0000-0002-7849-2135
Hornburg, Daniel
Babačić, Haris
Müller-Reif, Johannes B
Cantrell, Lee S
Edfors, Fredrik
Hauck, Stefanie M https://orcid.org/0000-0002-1630-6827
Deutsch, Eric W
Omenn, Gilbert S
Geyer, Philipp E https://orcid.org/0000-0001-7980-4826
Schwenk, Jochen M https://orcid.org/0000-0001-8141-8449
-
Funding
Funding for this research was provided by:
Kunt and Alice Wellanberg Foundation
HHS | NIH | National Institute of Environmental Health Sciences (P30ES017885-11-S1)
HHS | NIH | National Cancer Institute (U24CA271037)
- License Information
-
More Information
Article History
Received: 28 May 2026
Accepted: 29 May 2026
First Online: 9 June 2026
Disclosure and competing interests statement
: DH is employed by Bruker Daltonics and has financial interests in Seer Inc. and Prognomiq Inc. LSC is employed by Seer Inc. and has financial interests in Seer Inc. GSO serves on the boards of Galectin Therapeutics, MedsynBio, Eradix, and iReprogram Inc. FE is a co-founder of ProteomeEdge. PEG is a co-founder and employee of ions.bio. JMS serves as a scientific advisor for ABC Labs and has received travel support and/or speaker honoraria from Olink, Alamar Biosciences, and Illumina.
